TrialBreast cancer (Tokyo, Japan)2026
Venlafaxine reduces hot flashes in hormone receptor-positive breast cancer patients receiving tamoxifen: a prospective single-arm, open-label trial.
Riko Sato et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.